{"transactions":[{"id":4269396,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":174759,"kind":"person","name":"Creecy John W","position":1,"cik":"0001689143","reported_name":"Creecy John W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-06-30T17:22:11.000Z","date":"2017-06-28","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Automatic non-discretionary grant to the Reporting Person of a nonstatutory stock option under the Issuer's 2016 Equity Incentive Plan (the \"Plan\") in accordance with the Issuer's Amended and Restated Non-Employee Director Compensation Policy. One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the next annual meeting of the Issuer's stockholders following the date of grant, subject in each case to the Reporting Person's continued service on such vesting date."}],"balance_after":12000,"derivative":{"exercise_price":12.06,"expiration_date":"2027-06-27","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001209191-17-042572","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689143/000120919117042572/doc4.xml","form_type":"4"}},{"id":4509738,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":174759,"kind":"person","name":"Creecy John W","position":1,"cik":"0001689143","reported_name":"Creecy John W","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-12-30T08:33:58.000Z","date":"2016-12-29","kind":"other","acquired":true,"shares":1309392,"ownership":{"direct":false,"nature":"By Remeditex Ventures, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares of common stock of the corporation then known as Apollo Endosurgery, Inc. (\"Old Apollo\") were converted into shares of the Issuer pursuant to that certain Agreement and Plan of Merger and Reorganization, dated as of September 8, 2016, by and among the Issuer, Merger Sub, Inc. and Old Apollo (the \"Merger Agreement\"). Pursuant to the terms of the Merger Agreement, each share of common stock was converted into 0.3163 shares of the Issuer's common stock.  Following the merger, the Issuer effected a reverse stock split at a ratio of one new share for every five and one half shares of common stock outstanding."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares of common stock of the corporation then known as Apollo Endosurgery, Inc. (\"Old Apollo\") were converted into shares of the Issuer pursuant to that certain Agreement and Plan of Merger and Reorganization, dated as of September 8, 2016, by and among the Issuer, Merger Sub, Inc. and Old Apollo (the \"Merger Agreement\"). Pursuant to the terms of the Merger Agreement, each share of common stock was converted into 0.3163 shares of the Issuer's common stock.  Following the merger, the Issuer effected a reverse stock split at a ratio of one new share for every five and one half shares of common stock outstanding."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held in the name of Remeditex Ventures, LLC.  The Reporting Person is Chief Executive Officer and Director of Remeditex Ventures, LLC and may be deemed to be the beneficial owner of the securities held by Remeditex Ventures, LLC."}],"balance_after":1309392,"source":{"system":"sec-edgar","filing":"0001179110-16-033604","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689143/000117911016033604/edgar.xml","form_type":"4"}}]}